Audentes Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced operating loss was USD 47.077 million compared to USD 32.629 million a year ago. Net loss was USD 44.764 million compared to USD 31.367 million a year ago. Basic loss per share was USD 1.01 compared to USD 0.85 a year ago. For the half year, operating loss was USD 98.907 million compared to USD 59.039 million a year ago. Net loss was USD 94.155 million compared to USD 56.938 million a year ago. Basic loss per share was USD 2.14 compared to USD 1.59 a year ago.